Your browser is no longer supported. Please, upgrade your browser.
ECOR electroCore, Inc. daily Stock Chart
electroCore, Inc.
Index- P/E- EPS (ttm)-1.92 Insider Own26.10% Shs Outstand37.20M Perf Week-45.45%
Market Cap116.06M Forward P/E- EPS next Y-1.38 Insider Trans- Shs Float6.62M Perf Month-51.25%
Income-55.80M PEG- EPS next Q-0.51 Inst Own15.80% Short Float22.91% Perf Quarter-54.59%
Sales1.00M P/S116.06 EPS this Y-51.50% Inst Trans8.49% Short Ratio9.93 Perf Half Y-54.65%
Book/sh2.24 P/B1.39 EPS next Y28.90% ROA-63.40% Target Price20.60 Perf Year-
Cash/sh1.84 P/C1.69 EPS next 5Y- ROE-133.10% 52W Range2.82 - 20.25 Perf YTD-50.16%
Dividend- P/FCF- EPS past 5Y- ROI-83.20% 52W High-84.59% Beta-
Dividend %- Quick Ratio10.00 Sales past 5Y- Gross Margin41.70% 52W Low10.64% ATR0.50
Employees91 Current Ratio10.30 Sales Q/Q100.00% Oper. Margin- RSI (14)17.39 Volatility21.95% 9.38%
OptionableNo Debt/Eq0.00 EPS Q/Q-170.60% Profit Margin- Rel Volume1.18 Prev Close3.00
ShortableYes LT Debt/Eq0.00 EarningsMay 14 AMC Payout- Avg Volume152.72K Price3.12
Recom1.80 SMA20-45.31% SMA50-51.64% SMA200-65.27% Volume180,152 Change4.00%
May-15-19Downgrade BTIG Research Buy → Neutral
May-09-19Initiated Noble Capital Markets Outperform
Sep-21-18Initiated Cantor Fitzgerald Overweight
May-17-19 06:55PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of electroCore, Inc. Investors (ECOR) Business Wire -20.84%
May-16-19 10:00PM  Bragar Eagel & Squire, P.C. is Investigating electroCore, Inc. (NASDAQ: ECOR) on Behalf of electroCore Stockholders and Encourages electroCore Investors to Contact the Firm GlobeNewswire
07:01PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of electroCore, Inc. Investors (ECOR) Business Wire
May-14-19 04:05PM  electroCore Announces First Quarter 2019 Financial Results GlobeNewswire -6.82%
May-08-19 04:15PM  electroCore to Announce First Quarter 2019 Financial Results on Tuesday, May 14 GlobeNewswire
May-06-19 08:00AM  electroCore Selected for Innovation and Technology Payment Program Through NHS England GlobeNewswire
May-03-19 08:00AM  Real-World Evidence and Insights into gammaCore (nVNS) Mechanism of Action to be Presented at the American Academy of Neurologys 71st Annual Meeting GlobeNewswire
Apr-26-19 11:40AM  Have Insiders Been Buying electroCore, Inc. (NASDAQ:ECOR) Shares? Simply Wall St.
Mar-27-19 04:05PM  electroCore Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-18-19 04:05PM  electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27 GlobeNewswire +9.10%
Mar-14-19 08:00AM  electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore GlobeNewswire
Mar-08-19 05:08PM  4 Stocks Join Ben Graham Net-Net Screener Friday -6.67%
03:23PM  UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions GlobeNewswire
08:00AM  electroCore Appointments Multiple Industry Veterans to Key Management Positions GlobeNewswire
Feb-26-19 08:00AM  electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark GlobeNewswire
Feb-19-19 08:00AM  electroCore and HealthyWomen Announce Partnership on Patient Program to Increase Awareness of Non-Drug Migraine Therapies GlobeNewswire
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE
Jan-28-19 08:00AM  electroCore to Present at Noble Capital Markets Fifteenth Annual Investor Conference GlobeNewswire
Jan-08-19 08:00AM  electroCore Announces Two New Studies and a Publication Supporting the Practical Utility of Non-invasive Vagus Nerve Stimulation in Adults GlobeNewswire -19.09%
Jan-02-19 08:00AM  gammaCore Now Available Through U.S. Federal Governments Federal Supply Schedule (FSS) GlobeNewswire +13.58%
Dec-21-18 10:36AM  Is electroCore, Inc.s (NASDAQ:ECOR) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Nov-28-18 08:03AM  electroCore Receives FDA Clearance for gammaCore (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults GlobeNewswire +7.04%
07:25AM  FDA Changes Will Reward Medical Device Innovation: Heres What Investors Need to Know ACCESSWIRE
Nov-27-18 08:00AM  electroCore Expands Manufacturing Capabilities for gammaCore GlobeNewswire
Nov-21-18 07:50AM  Market Trends Toward New Normal in Tandy Leather Factory, Boxlight, Willamette Valley Vineyards, electroCore, FAT Brands, and Village Super Market Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-20-18 04:05PM  electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference GlobeNewswire -6.88%
Nov-13-18 04:05PM  electroCore, Inc. Announces Third Quarter Financial Results GlobeNewswire -15.02%
Nov-09-18 08:40AM  NICE publishes advice on gammaCore for the treatment of cluster headache in the UK GlobeNewswire
Oct-30-18 04:05PM  electroCore, Inc. to Report Third Quarter Financial Results on November 13, 2018 GlobeNewswire
08:00AM  electroCore, Inc. Announces Appointment of Ardelle Ferris as Vice President of Managed Care GlobeNewswire
Sep-25-18 11:22AM  Who Really Owns electroCore Inc (NASDAQ:ECOR)? Simply Wall St.
Sep-18-18 04:05PM  electroCore, Inc. to Present at the Cantor Global Healthcare Conference GlobeNewswire
Sep-05-18 04:05AM  electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation in Headache Disorders at the 17th Biennial Migraine Trust International Symposium GlobeNewswire
Aug-13-18 04:05PM  electroCore, Inc. Announces Second Quarter Financial Results GlobeNewswire +6.00%
Aug-09-18 08:00AM  electroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-Invasive Vagus Nerve Stimulation in Neuroinflammation GlobeNewswire
Aug-01-18 08:00AM  Next Generation nVNS Therapy gammaCore Sapphire Now Available for Patients with Migraine and Episodic Cluster Headache in United States GlobeNewswire
Jul-26-18 04:05PM  electroCore, Inc. to Report Second Quarter Financial Results on August 13, 2018 GlobeNewswire
Jul-17-18 08:00AM  electroCore and UpScript Launch Program to Offer Direct-to-Patient Telemedicine Option for gammaCore in the United States GlobeNewswire +8.95%
Jul-10-18 08:00AM  electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering GlobeNewswire
Jun-28-18 04:01PM  electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation (nVNS) in Headache Disorders at the 60th Annual Meeting of the American Headache Society GlobeNewswire
11:45AM  electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering GlobeNewswire
Jun-26-18 10:58AM  electroCore, Inc. Announces Closing of Initial Public Offering GlobeNewswire
Jun-22-18 07:07PM  [$$] Autolus, ElectroCore IPOs Cap Strong Week for Life Sciences The Wall Street Journal
Jun-20-18 03:11PM  8 Biotech Stocks With IPOs This Week InvestorPlace
Jun-17-18 04:22PM  The IPO Outlook For The Week Of June 18: Pharma, Pharma And More Pharma Benzinga
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.